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Abstract	
1 
2 
3 
4 Aims:	Previous	research	suggests	that	patients	undergoing	upper	gastrointestinal	surgery	are	at	high	
5 
6 risk	of	poor	postoperative	outcomes.	The	aim	of	our	study	was	to	describe	patient	outcomes	after	
7 elective	upper	gastrointestinal	surgery	at	a	global	level.	
9 
10 
11 Methods:	Prospective	analysis	of	data	collected	during	an	 international	seven-day	cohort	 study	of	
12 
13 474		hospitals		in		27		countries.		Patients		undergoing		elective		upper		gastrointestinal		surgery	 were	
14 
15 recruited.	Outcome	measures	were	 in-hospital	complications	and	mortality	at	30-days.	Results	are	
16 presented	as	n(%)	and	odds	ratios	with	95%	confidence	intervals.	17 
18 
19 
20 Results:	2139	patients	were	 included,	of	whom	498	(23.2%)	developed	one	or	more	postoperative	
21 
22 complications,	with	30		deaths	(1.4%).		Patients		with	complications	had	longer		median	hospital	 stay	
23 11	(6-18)	days	vs.	5	(2-10)	days.	Infectious	complications	were	most	frequent,	affecting	368	(17.2%)	
25 patients.	328	(15.3%)	patients	were	admitted	to	critical	care	postoperatively,	of	whom	161	(49.1%)	
26 
27 developed	 a	 complication	with	 14	 deaths	 (4.3%).	 In	 a	multivariable	 logistic	 regression	model	 we	
28 
29 identified		age	(OR	1.02		[1.01-1.03]),		American		Society		of		Anesthesiologists		physical		status	III	(OR	
30 
31 2.12		[1.44-3.16])		and		IV		(OR		3.23		[1.72-6.09]),		surgery		for		cancer		(OR		1.63		[1.27-2.11]),		open	32 procedure	(OR	1.40	[1.10-1.78]),	intermediate	surgery	(OR	1.75	[1.12-2.81])	and	major	surgery	(OR	
33 
34 2.65	 [1.72-4.23])	 as	 independent	 risk	 factors	 for	postoperative	 complications.	Patients	undergoing	
35 
36 major		 surgery		 for		upper		gastrointestinal		cancer		experienced		 twice		 the		 rate		of		 complications	
37 
38 compared		to		 those		undergoing		other		procedures		(224/578		patients		 [38.8%]		versus		274/1561	
39 patients	[17.6%]).	
41 
42 
43 Conclusions:		Complications		and		death		are		common	after		upper		gastrointestinal		surgery.	Patients	
44 
45 undergoing	major	surgery	for	cancer	are	at	greatest	risk.	
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Introduction	
1 
2 Currently,	310		million	patients	undergo	surgery	worldwide	each	year,	with	more		procedures		taking	
3 
4 place	in	high-income	countries.[1,2]	Estimates	of	mortality	following	in-patient	surgery	vary	from	1	
5 
6 to		4%,[3-10]		but		it		is		now		recognised		that		selected		high-risk		patient		groups		are		more		likely	to	
7 develop	 life	 threatening	 complications.	 Postoperative	 complications	 increase	 treatment	
9 costs,[11,12]	 and	 reduce	 both	 life	 expectancy	 and	 quality	 of	 life	 at	 a	 societal	 level.[3,14]	Whilst	
10 
11 technical	 errors	 are	 unusual	 during	 surgery	 and	 anaesthesia,	 poor	 patient	outcomes	 persist	 for	 a	
12 
13 variety	 of	 reasons.	 Improvements	 in	 the	 quality	 of	 perioperative	 care	 for	 high-risk	 patients	 may	
14 
15 therefore	lead	to	better	patient	outcomes.	
16 
17 
18 Patients	 undergoing	 surgery	 to	 treat	 cancer	 of	 the	 upper	 gastrointestinal	 tract	 are	 an	 important	
19 
20 high-risk	group.	This	includes	cancers	of	the	oesophagus,	and	stomach,	which	have	a	poor	 long-term	
21 
22 prognosis.		Worldwide,		oesophageal		cancer		is		the		sixth		leading		cause		of		death		from	cancer.[15]	
23 Surgical	resection	remains	the	only	potentially	curative	treatment,	and	is	integrated	in	a	multimodal	
25 therapy,	particularly	for	advanced	disease.	Recent	data	from	the	United	Kingdom	suggest	one	third	
26 
27 of		patients		undergoing		oesophageal		and		gastric		surgery		 for		cancer,		experience		postoperative	
28 
29 complications,		with		hospital		mortality		 rates		 in		 the		 region		of		3%.[16]		Other		 reports		describe	
30 
31 complication		rates		between		40		and		80%,		depending		on		age,		gender,		type		of		surgery,		and		 the	
32 presence	of	chronic	disease.[17,18]	33 
34 
35 
36 The	need	remains	to	better	understand	patient	outcomes	following	upper	gastrointestinal	surgery,	
37 
38 to		ensure		the		planning		of		effective		perioperative		care,		including		appropriate		patient		 selection,	
39 surgical			approach			and			postoperative			provision			of		critical			care.[14]		The			International	Surgical	
41 Outcomes		Study		(ISOS)		was		recently		conducted		to		evaluate		the		incidence		and		risk		factors		for	
42 
43 complications	and	death	after	 in-patient	elective	surgery	at	a	global	 level,	and	to	describe	current	
44 
45 standards	of	postoperative	care.[19]	 ISOS	included	a	prospective	sub-group	analysis	 to	describe	 in	
46 
47 detail,	 the	 clinical	 outcomes	 and	 standards	 of	 perioperative	 care	 following	 upper	 gastrointestinal	
48 surgery		at	a	global	level,	and	to		describe		factors	associated	with		complications	during	the		hospital	
50 stay	and	death	in	this	population.	
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Patients	and	Methods	
1 
2 Project	organisation	
3 
4 ISOS	was	approved	by	the	Yorkshire	&	Humber	Research	Ethics	Committee	(Reference:	13/YH/0371).	
5 
6 We	then	conducted	a	sub-group	analysis	of	data	collected	during	this	international	seven-day	cohort	
7 study		of		outcomes		following		elective		adult		in-patient		surgery.		Regulatory		requirements	differed	
9 between		countries		with		some		requiring		research		ethics		approval		and		some		requiring		only	data	
10 
11 governance	 approval.	 Each	 participating	 country	 selected	 a	 single	 data	 collection	 week	 between	
12 
13 April		and		August		2014.		Patient		data		included		only		that		recorded		as		part		of		routine		care.	Local	
14 
15 investigators	were	supported	by	national	co-ordinators,	the	international	study	management	 group,	
16 and		via		a		website		which		provided		all		study		documentation		and		guidance		on		study		procedures	17 
18 (www.isos.org.uk/documents).			The			main			ISOS			project			was			registered			prospectively			with		 an	
19 
20 international	 trial	 registry	 (ISRCTN51817007).	 The	manuscript	has	been	prepared	according	 to	 the	
21 
22 STROBE	statement.[20]	
23 
24 
25 The	 inclusion	 criteria	 were	 all	 adult	 patients	 (age	 ≥18	 years)	 undergoing	 elective	 surgery	 with	 a	
26 
27 planned	 overnight	 stay	 in	 hospital.	 Patients	 undergoing	 emergency	 surgery,	 day-case	 surgery	 or	
28 
29 radiological	 procedures	 were	 excluded.	We	 aimed	 to	 recruit	 as	 many	 hospitals	 and	 countries	 as	
30 
31 possible	and	asked	 investigators	 in	those	hospitals	 to	enrol	all	eligible	patients.	No	 formal	sample	
32 size		calculation		was		performed.		Only		hospitals		returning		valid		data		describing		≥20		patients	and	33 
34 countries		with		≥10		participating		hospitals		were		 included		 in		the		primary		analysis		of		the		 ISOS	
35 
36 dataset.[19]				In			this				sub-group				analysis,			we				included				all			patients			who			underwent		 upper	
37 
38 gastrointestinal	 surgery	 by	 the	 thoracic	 or	 abdominal	 route,	 using	either	 an	open	or	 laparoscopic	
39 technique,	identified	via	the	e-CRF.[19]	We	also	investigated	whether	there	were	any	differences	in	
41 outcomes	between	high-income	countries,	and	low	or	middle-income	countries.	
42 
43 
44 
45 Data	collection	
46 
47 Data		describing	consecutive		patients	were		collected	until	hospital	discharge	on	paper		case		 record	
48 forms.	Data	were	censored	at	30	days	following	surgery	for	patients	who	remained	in	hospital.	Data	
50 were	anonymised	before	entry	onto	a	secure	internet-based	electronic	case	record	form	designed	
51 
52 specifically		 for		 ISOS,		 which		 incorporated		 automated		 checks		 for		 plausibility,		 consistency		 and	
53 
54 completeness.	
55 
56 
57 Outcome	measures	
58 
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The			primary			outcome			measure			was			in-hospital			postoperative			complications			assessed			using	
1 
2 predefined	criteria	and	graded	according	 to	 the	Clavien-Dindo	classification.[21,22]	The	secondary	
3 outcome	measure	was	 in-hospital	mortality.	 Process	measures	were	 admission	 directly	 to	 critical	
5 care	 after	 surgery,	 admission	 to	 critical	 care	 for	 treatment	 of	 a	 postoperative	 complication,	 and	
6 
7 duration	of	hospital	stay.	A	single	prospective	definition	of	critical	care	was	used	for	all	countries	(a	
8 
9 facility	routinely	capable	of	admitting	patients	who	require	invasive	ventilation	overnight).	
10 
11 12 Statistical	analysis	
13 
14 Statistical	analysis	was	performed	using	SPSS	(version	20.0)	and	R:	A	language	and	environment	for	
15 
16 statistical	computing	(R	Foundation	for	Statistical	Computing,	Vienna,	Austria).	Categorical	variables	
17 
18 are	presented	as	number	(%)	and	continuous	variables	as	mean	(SD)	where	normally	distributed	and	
19 median	(IQR)	where	not	normally	distributed.	Univariable	analysis	was	used	to	select	risk	factors	for	
21 postoperative	complications.	Multivariable	logistic	regression	analysis	was	used	to	develop	a	generic	
22 
23 model	 in	which	all	previously	determined	risk	 factors	were	entered.	The	threshold	 for	 inclusion	of	
24 
25 variables	in	the	multivariable	analysis	was	p<0.05.	All	predictors	were	entered	into	the	model	using	
26 
27 forced	simultaneous	entry.		With		the	expected	sample		size,		a		limited		number	of		factors	could		 be	
28 included	in	the	model	without	over	fitting,	and	these	were	selected	based	on	clinical	suitability	and	29 
30 assessment	of	correlated	variables.	Bootstrapping	was	used	to	assess	the	reliability	of	the	models.	
31 
32 Goodness-of-fit		tests		were	performed	using	the	Hosmer-Lemeshow		test.	A	process	of	forward		and	
33 
34 backward	 selection,	 based	 on	 minimisation	 of	 Akaike’s	 Information	 Criterion	 (AIC),	 was	 used	 to	
35 derive	the	final	model.[23]	Results	are	presented	as	odds	ratios	with	95%	confidence	intervals.	For	
37 variables	included	in	our	final	model,	univariable	logistic	regression	was	then	performed	to	 generate	
38 
39 unadjusted	odd	ratios	for	comparison	with	the	multivariable	model.	In	the	main	ISOS	database,	 data	
40 
41 describing	 baseline	 risk	 factors	were	missing	 for	 a	 very	 small	 proportion	 of	 patients	 [451/44	 814	
42 
43 (1%)].	Due	 to	 the	 low	 proportion	of	missing	 data,	we	 performed	 a	 complete	 case	 analysis	where	
44 patients	with	missing	data	were	excluded	from	the	analysis.[19]	45 
46 
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Results	
1 
2 Data		describing		44		814		patients		were		collected		in		474		hospitals		in		the		following		countries	and	
3 
4 regions:	Australia,	Austria,	Belgium,	Brazil,	Canada,	China,	Denmark,	France,	Germany,	Greece,	Hong	
5 
6 Kong,		Indonesia,		Italy,		Malaysia,		Netherlands,		New		Zealand,		Nigeria,		Portugal,		Romania,	 Russia,	
7 South		Africa,		Spain,		Sweden,		Switzerland,		Uganda,		United		Kingdom,		and		the		United		States		of	
9 America.	Fewer	than	ten	hospitals	participated	in	India,	Iraq	and	Mexico	and	in	accordance	with	the	
10 
11 prospective	 statistical	 analysis	 plan,	 patients	 recruited	 in	 these	 countries	were	excluded	 from	 the	
12 
13 primary	analysis.	2139	patients	who	underwent	upper	gastro-intestinal	surgery	in	369	centres	were	
14 
15 identified	 in	 the	 ISOS	 database	 (4	 [2-7]	 patients	 per	 centre;	 Figure	 1).	 Baseline	 patient	 data	 are	
16 presented	in	Table	1.	17 
18 
19 
20 Process	measures	
21 
22 The		median		stay		in		a		post-anaesthetic		care		unit		was		2		(1-3)		hours.		328		(15.3%)		patients	were	
23 admitted	to	a	critical	care	unit	as	routine	immediately	after	surgery,	with	a	median	critical	care	stay	
25 of	1	(1-4)	days.	Of	these	patients,	161	(49.1%)	developed	a	complication	with	14	(4.3%)	deaths.	121	
26 
27 patients	were	admitted	to	a	critical	care	unit	 to	 treat	 complications,	of	whom	17	 (14%)	died.	The	
28 
29 median	duration	of	critical	care	stay	for	patients	admitted	to	treat	a	complication	was	5	(1-10)	days.	
30 
31 The	median	 overall	 hospital	 stay	 was	 5	 (2-10)	 days,	 increasing	 to	 11	 (6-18)	 days	 amongst	 those	
32 patients	who	developed	complications.	33 
34 
35 
36 Clinical	outcomes	
37 
38 In		total,		498		(23.2%)		patients		developed		complications		in		hospital,		and		30		died		before	hospital	
39 discharge	 (1.4%).	 297	 (13.9%)	 patients	 developed	 a	 single	 postoperative	 complication	whilst	 201	
41 (9.4%)	patients	developed	two	or	more	complications.	Data	describing	postoperative	complications	
42 
43 are	presented	in	Table	2.	There	were	368	infectious	complications	affecting	254	patients,	the	most	
44 
45 frequent	being	pneumonia	and	superficial	surgical	site	infections	of	varying	severity	(Table	2).		There	
46 
47 were		125		complications		affecting		97		patients		related		to		technical		aspects		of		surgery,		such		as	
48 postoperative		bleeding	and	anastomotic	leak	(Table	2).		The	“All		 other”		category		of		complications	
50 were		not		 specified		and		 included		deep		vein		 thrombosis,		 ileus,		pancreatitis		etc.		Nine		patients	
51 
52 experiencing			complications			in			this			category			died,		however,			all			had			additionally	 experienced	
53 
54 infectious,	cardiovascular,	or	other	complications	related	to	the	technical	aspects	of	the	procedure.	
55 In		 the		 initial		 univariable		 regression		 analysis,		 age		 (OR		 1.03		 [1.02-1.04]),		 American		 Society		 of	
57 Anesthesiologists	 (ASA)	 physical	 status	 score	 III	 (OR	 3.33	 [2.32-4.78])	 or	 IV	 (OR	 5.51	 [3.07-9.88]),	
58 
59 surgery			for			cancer			(OR			2.60			[2.11-3.21]),			non-laparoscopic			surgery			(OR			1.79			[1.45-2.21]),	
59 
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intermediate		surgery		(OR	1.81	[1.19-2.75]),		major	surgery		(OR	4.34		[2.91-6.48])		and	cirrhosis	(OR	
1 
2 2.28	[1.05-4.95])	were	identified	as	risk	factors	for	postoperative	complications.	However	during	 the	
3 multivariable	logistic	regression	analysis	when	adjusted	for	cofounders,	only	age,	ASA	status,	surgery	
5 for			cancer,			non-laparoscopic			surgery,			intermediate			and			major			surgery			were			identified			as	
6 
7 independent		risk		factors		for		postoperative		complications		(Table		3).		This		indicated		major		 upper	
8 
9 gastrointestinal		surgery		to		treat		cancer		as		a		sub-population		at		particular		risk		of	poor	outcomes	
10 
11 (Supplementary		Table		1),		with		twice		the		rate		of		complications		(224/578		major		cancer		patients	
12 [38.8%]	versus	274/1561		[17.6%]		patients		undergoing		minor,	intermediate,			or		major		non-cancer	13 
14 procedures		(Figure		2).		In		the		major		cancer		surgery		group,		122		(21.1%)		patients		developed	one	
15 
16 complication,		whilst		102		(17.6%)		patients		developed		two		or		more		complications		during		their	
17 
18 postoperative	stay	in	hospital.	Of	2139	patients	who	underwent	upper	gastrointestinal	surgery,	30	
19 died		(1.4%).		Non-survivors			were		older,			had		higher		ASA		scores			and			underwent		major		surgery	
21 (Supplementary	Table	2).	
22 
23 
24 
25 Comparison	of	high-income	and	low	or	middle-income	countries:	
26 
27 Using	the	World	Bank	classification,	eight	were	classed	as	 low	or	middle-income	countries	 (Brazil,	
28 China,	 Indonesia,	Malaysia,	 Nigeria,	 Romania,	 South	Africa,	 and	Uganda),	 and	 19	were	 classed	 as	29 
30 high-income		countries		(Australia,		Austria,		Belgium,		Canada,		Denmark,		France,		Germany,	Greece,	
31 
32 Hong	Kong,	 Italy,	Netherlands,	New	Zealand,	Portugal,	Russia,	Spain,	Sweden,	Switzerland,	United	
33 
34 Kingdom,	and	the	United	States	of	America).[24]	Patient	outcomes	for	major	cancer	surgery	in	high-	
35 income	countries	were	similar	to	the	overall	international	sub-group	with	326/1270	patients	(25.7%)	
37 developing	complications	with	six	deaths	(2.3%).	 In	this	post-hoc	analysis,	complication	rates	were	
38 
39 lower	 in	 the	 low	 or	 middle-income	 countries	 172/869	 (19.8%)	 p<0.001.	 When	 explored	 this	 we	
40 
41 found	that	although	age	was	similar	in	both	the	high	and	low	or	middle-income	countries	57	(44-68)	
42 
43 vs	58	(46-66)	years,	ASA	distribution	significantly	differed	with	more	ASA	2,	3	and	4	patients	being	
44 operated	in	the	high	income	countries	(Supplementary	Figure	1).	Patients	in	high-income	countries	45 
46 underwent	fewer	minor	procedures	(Supplementary	Figure	2).	There	were	no	significant		differences	
47 
48 between		high		or		 low		 and		middle-income		 countries		 in		 terms		of		 risk		of		complications		 in		 the	
49 
50 univariable	analysis.	
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Discussion	
1 
2 We	 report	 data	 from	an	 international	 prospective	 cohort	 study	 describing	 detailed	 postoperative	
3 
4 outcomes	for	a	population	of	more	than	2,000	patients	undergoing	elective	upper	gastrointestinal	
5 
6 surgery	in	27	countries	worldwide.	The	principal	findings	were	that	one	in	four	patients	experienced	
7 a	complication	before	hospital	discharge,	compared	to	one	in	six	of	the	overall	surgical	population	 in	
9 the	parent		study.[19]	Surgery		involving	the	upper		gastrointestinal	tract		was	associated	with	higher	
10 
11 risk		of	complications		compared	to	the		reference		category		of	orthopaedic	surgery		in		the	complete	
12 
13 ISOS	dataset.[19]	According	to	our	results,	complications	in	the	upper	gastrointestinal	surgery	 group	
14 
15 were	associated	with	a	two-fold	increase	in	hospital	stay,	and	one	in	fifteen	patients	who		developed	
16 a		complication		died	before		hospital		discharge.		Patients		undergoing	major	cancer		surgery		are			 at	17 
18 particular	 risk,	with	twice	 the	postoperative	complication	rate	of	other	patients	undergoing	upper	
19 
20 gastrointestinal		surgery.		In		the		univariable		analysis,		risk	of		complication	was		similar	when			 high-	
21 
22 income	countries	were	compared	to	low	and	middle-income	countries.	Our	results	suggest	that	the	
23 greater	crude		complication	rates		in	high-income		countries	largely		relate		to	differences	in	casemix.	
25 This	finding	suggests	that	measures	to	reduce	complication	rates	remain	important	in	all	countries,	
26 
27 regardless	of	income	status.	
28 
29 
30 
31 The	complication	rates	observed	 in	this	analysis	are	 lower	 than	those	 reported	 in	 recently	studies	
32 from		Sweden,		Japan,	Australia		and		the	UK.[16,25-27]		The		Australian,		Japanese	and		UK	studies	all	33 
34 reported		complications		during		hospital		stay,		similar		to		our		methods.		Unlike		our		contemporary	
35 
36 snapshot	of	practice,	these	studies	collected	information	on	patients	over	several	years.[25-27]	The	
37 
38 ongoing	change	and	improvement	in	clinical	practice	over	the	last	decade	might	partly	account	for	
39 the	 lower	observed	 complication	 rates	 in	our	 series.[28]	 Infectious	 complications	 such	as	 surgical	
41 site		infections	and	pneumonia		remain	commonplace,		and		are	associated	with		 prolonged		hospital	
42 
43 stays.			 In			previous			studies,			pneumonia			rates			as			high			as			22.5%			were			reported			 following	
44 
45 oesophagectomy,	whereas	in		our		series	the		rate	was	only	4.0%,	even		in		the	major		cancer	 surgery	
46 
47 sub-group.[16,25-27]		Similarly,	technical	complications	of	surgery	were	less	frequent	in	this	dataset,	
48 although	 this	 may	 relate	 to	 differences	 in	 casemix	 and	 improvements	 in	 surgical	 technique	 and	
50 perioperative		care		compared		to		the		standards		observed		in	previous		studies		in	this	 international	
51 
52 patient	sample.	[16,25-27]	
53 
54 
55 Mortality	rates	were	lower	than	expected	given	the	observed	complication	rates.	It	is	possible	that	
56 
57 this	relates	to	improvements	in	the	care	of	patients	who	develop	complications,	although	this	may	
58 also		be		affected		by		the		duration		of		critical		care		stay		for		patients		who		develop		life	threatening	
59 
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20 
36 
53 
complications		after		major		elective		surgery,		which		may		now		routinely		exceed		30		days		before	
1 
2 treatment	is	withdrawn	for	reasons	of	futility.	In	this	context,	30-day	mortality	may	not	truly	reflect	
3 the		seriousness		of		eventual		patient		outcomes.		The		risk		factors		for		postoperative		complications	
5 identified	in	the	ISOS	study	are	well	recognised.	Age	has	been	shown	to	be	independently	associated	
6 
7 with	 higher	 post-operative	 morbidity	 and	 mortality	 after	 major	 upper	 gastrointestinal	
8 
9 procedures,[29-31]		although		age		alone		should		not		be		viewed		as		a		reason		to		deny		patients		a	
10 
11 definitive		 surgical		 treatment.		A		 recent		Australian		study		did		not		demonstrate		any		 correlation	
12 between	age	and	long-term	survival,	even	though	postoperative	complications	were	more	frequent	13 
14 amongst	elderly	patients.[31]	The	 findings	 from	our	 larger	 international	 study	are	 consistent	with	
15 
16 this	previous	work,	confirming	the	high	incidence	of	complications	early	after	upper	gastrointestinal	
17 
18 surgery		 amongst		 elderly		 patients.		 ASA		 score		 has		 been		 highlighted		 as		 a		 strong		 predictor		 of	
19 postoperative	complications.[32]	It	is	interesting	to	note	that	a	relatively	large	proportion	of	patients	
21 undergoing	 upper	 gastrointestinal	 surgery	were	 classed	 as	 ASA	 III	 or	 IV,	 in	 both	 cancer	 and	 non-	
22 
23 cancer		cancer		groups,		with		a		corresponding		increase		in		the		frequency		of		complications.	Similar	
24 
25 findings			have			recently			been			reported			in			the			UK,			with			one			third			of			patients			undergoing	
26 
27 oesophagectomy		 falling		 into		ASA		 III		 and		 IV		 categories.[33]		Recent		 recommendations		 for		 the	
28 treatment			of			upper			gastrointestinal			cancer			recommend			careful			patient			selection			based		 on	29 
30 physiological	 reserve	 and	pre-existing	 co-morbid	disease.[34,35]	One	 in	 six	 patients	 in	 this	 cohort	
31 
32 were		 admitted		 to		 a		 critical		 care		 unit		 immediately		 after		 surgery,		 half		 of		whom		 experienced	
33 
34 postoperative	 complications.	Although	 significant	 progress	has	been	made	 in	 the	development	of	
35 perioperative			pathways			to			improve			patient		outcomes,			it			remains			uncertain			what			the	most	
37 appropriate	level	of	postoperative	care	should	be	for	this	high-risk	patient	group.	This	is	highlighted	
38 
39 in	the	findings	of	a	recent	analysis	of	a	large	US	dataset,	which	did	not	identify	any	benefit	of	routine	
40 
41 critical		care		admission		immediately		after		major		upper		gastrointestinal		cancer		surgery.[36]		The	
42 
43 secondary	analysis	of	the	 ISOS	dataset	also	 failed	to	signal	any	mortality	benefit	of	 routine	critical	
44 care	admission	following	high-risk	elective	surgery.[37]	45 
46 
47 The	strengths	of	this	study	have	been	discussed	in	detail	in	our	previous	publication.[19]	We	used	a	
48 
49 very		 simple		data		 set		 consisting		 primarily		 of		 categorical		 variables		 to		 aid		data		 collection		 and	
50 
51 minimising		empty		data		fields.		Patient-level		variables		were		selected	on		the		basis		that		they	were	
52 objective,	 and	 routinely	 available	 to	 local	 investigators.	 We	 carefully	 defined	 surgical	 procedure	
54 categories		to		 identify		patients		undergoing		major		upper		gastrointestinal		surgery		by		either		the	
55 
56 abdominal		or		thoracic		route.	We		also		asked	investigators		to		confirm		whether		the		indication	 for	
57 
58 surgery	was	cancer.	The	study	also	has	a	number	of	weaknesses.	The	ISOS	project	was		prospectively	
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4 
designed	to	allow	us	to	clearly	identify	patients	undergoing	upper	gastrointestinal	surgery,	but	its’	
1 
2 main	objective	was	to	evaluate	all	elective	in-patient	surgery.	Baseline	data	were	not	specific	to	the	
3 upper		gastrointestinal		surgical		procedure		category,		and		our		multivariable		model		may		not		fully	
5 account	 for	 high	mortality	 rates	 in	hospitals	 specialising	 in	more	 complex	 surgery	 due	 to	 the	 low	
6 
7 number	of	patients	recruited	in	each	centre.	It	is	possible,	that	given	the	pragmatic	nature	of	ISOS	
8 
9 study	 looking	at	only	 complications	during	 the	hospital	 stay,	we	missed	some	of	 the	 later	 events,	
10 
11 possibly	resulting	in	an	under-estimate	of	the	incidence	of	postoperative	complications.	Also,	due	 to	
12 the		pragmatic		nature		of		the		study,		external		verification		of		the		imputed		data		was		not	possible,	13 
14 potentially	 resulting	 in	misreporting	of	 complications.	However,	 the	 similar	 studies	 from	different	
15 
16 countries	also	limited	their	data	collection	period	to	in-hospital	stay	or	30	days	postoperatively	and	
17 
18 suffered	from	lack	of	external	data	verification.[16,25-28]	
19 
20 
21 Conclusions	
22 
23 The	 findings	 of	 this	 international	 cohort	 study	 indicate	 that	 a	 large	 number	 of	 patients	 develop	
24 
25 complications		after		elective		in-patient		upper		gastrointestinal		surgery.		Patients		undergoing	major	
26 
27 cancer	surgery	were	at	particular	risk	with	complication	rates	approaching	one	in	two	patients.		 To	
28 improve	patient	outcomes,	the	concept	of	perioperative	medicine	is	being	adopted	more	widely	to	29 
30 ensure	safe	and	effective	patient	care	throughout		the	perioperative	care	pathway.[39]	International	
31 
32 datasets	help	to	set	out	the	baseline	for	further	quality	improvement	initiatives	and	can	be	used	for	
33 
34 perioperative	decision-making	and	informed	consent	during	upper	gastrointestinal	surgery.	
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	Table 1. 
 
 
 
 
 
Table	1.	Baseline	patient	characteristics.	Data	presented	as	n	(%)	or	mean	(SD).	ASA,	American	Society	
of	Anesthesiologists	 physical	 status	 score;	 COPD,	 chronic	 obstructive	 pulmonary	 disease.	We	 compared	 patients	
with	 or	 without	 complications,	 using	 Mann-Whitney	 U	 and	 Chi-square	 tests	 as	 appropriate.	 *	 signifies	 p<0.05	
compared	to	patients	with	complications.	
	
	
 
All	patients	
(n=2139)	
Patients	with	
complications	
(n=498)	
Patients	without	
complications	
(n=1641)	
Age	 56	(16)	 61	(15)	 55	(16)*	
Male	 1034	(48.3%)	 271	(54.5%)	 761	(46.3%)*	
Female	 1108	(51.7%)	 227	(45.6%)	 881	(53.7%)*	
Smoker	 397	(18.8%)	 101	(20.3%)	 295	(18.3%)	
Black	ethnicity	 190	(9.0%)	 32	(6.5%)	 158	(9.8%)*	
ASA	score	  
I	 337	(15.8%)	 43	(8.7%)	 294	(17.9%)*	
II	 1104	(51.7%)	 219	(44.1%)	 884	(54.0%)*	
III	 631	(29.5%)	 206	(41.4%)	 424	(25.9%)*	
IV	 65	(3.0%)	 29	(5.8%)	 36	(2.2%)*	
Severity	of	surgery	  
Minor	 297	(13.9%)	 30	(6.0%)	 267	(16.3%)*	
Intermediate	 857	(40.0%)	 145	(29.1%)	 712	(43.4%)*	
Major	 985	(46.0%)	 322	(64.7%)	 661	(40.3%)*	
Chronic	disease	  
Ischaemic	heart	disease	 189	(8.9%)	 59	(11.8%)	 130	(8.0%)*	
Heart	failure	 83	(3.9%)	 28	(5.6%)	 55	(3.4%)*	
Diabetes	mellitus	 309	(14.5%)	 79	(15.9%)	 229	(14.0%)	
Cirrhosis	 27	(1.3%)	 11	(2.2%)	 16	(1.0%)*	
Surgery	for	Cancer	 750	(35.1%)	 269	(54.0%)	 479	(31.7%)*	
Metastatic	cancer	 140	(6.6%)	 54	(10.8%)	 86	(5.3%)*	
Stroke	 73	(3.4%)	 22	(4.4%)	 51	(3.1%)	
COPD/Asthma	 240	(11.3%)	 62	(12.4%)	 178	(10.9%)	
Other	chronic	disease	 926	(43.4%)	 259	(52.0%)	 630	(38.6%)*	
Blood	test	results	  
Haemoglobin	(g/dL)	 12.7	(2.1)	 12.3	(2.2)	 12.9	(2.1)*	
Creatinine	(µmol/L)	 79	(53)	 84	(54)	 77	(52)*	
Sodium	(mmol/L)	 139	(6)	 139	(8)	 140	(5)	
Leucocytes	(x10-9/mm3)	 7.7	(4.6)	 8.4	(7.6)	 7.4	(2.9)	
Laparoscopic	technique	 936	(43.7%)	 165	(33.1%)	 770	(47.0%)*	
	Table 2. 
 
 
 
 
 
Table	2.	Complication	rates	for	patients	undergoing	elective	upper	gastrointestinal	
surgery	using	the	Clavien-Dindo	classification	(I	to	V).	Percentages	expressed	as	a	proportion	of	
all	patients	included	in	the	analysis	(n=2139).	ARDS,	acute	respiratory	distress	syndrome.	
	
	
 Severity	
class	I	
Severity	
class	II	
Severity	
class	III	
Severity	
class	IV	
Severity	class	
V	
Cumulative	
complication	
rate	
Infection	
Pneumonia	N	(%)	 31	(1.4%)	 46	(2.1%)	 0	(0%)	 21	(1.0%)	 10	(0.5%)	 108	(5.0%)	
Superficial	surgical	site	
N	(%)	 42	(2.0%)	 28	(1.3%)	 5	(0.2%)	 3	(0.1%)	 1	(0.1%)	 79	(3.7%)	
Body	cavity	N	(%)	 24	(1.2%)	 19	(0.9%)	 0	(0%)	 19	(0.9%)	 2	(0.1%)	 64	(3.0%)	
Deep	surgical	site	N	(%)	 12	(0.6%)	 25	(1.2%)	 0	(0%)	 12	(0.6%)	 4	(0.2%)	 53	(2.5%)	
Bloodstream	N	(%)	 11	(0.5%)	 14	(0.7%)	 1	(0.1%)	 9	(0.4%)	 6	(0.3%)	 41	(1.9%)	
Urinary	tract	N	(%)	 12	(0.6%)	 14	(0.7%)	 0	(0%)	 1	(0.1%)	 4	(0.2%)	 31	(1.4%)	
Cardiovascular	
Arrhythmia	N	(%)	 35	(1.6%)	 36	(1.7%)	 3	(0.1%)	 8	(0.4%)	 6	(0.3%)	 88	(4.1%)	
Pulmonary	oedema	N	
(%)	 14	(0.7%)	 4	(0.2%)	 0	(0%)	 3	(0.1%)	 1	(0.1%)	 22	(1.0%)	
Cardiac	arrest	N	(%)	 -	 -	 -	 5	(0.2%)	 9	(0.5%)	 14	(0.7%)	
Myocardial	infarction	N	
(%)	 1	(0.1%)	 2	(0.1%)	 0	(0%)	 3	(0.1%)	 2	(0.1%)	 8	(0.4%)	
Pulmonary	embolism	N	
(%)	 1	(0.1%)	 3	(0.1%)	 0	(0%)	 2	(0.1%)	 0	(0%)	 6	(0.3%)	
Stroke	N	(%)	 1	(0.1%)	 0	(0%)	 0	(0%)	 2	(0.1%)	 3	(0.2%)	 6	(0.3%)	
Other	complications	
Post-operative	bleeding	
N	(%)	 -	 56	(2.6%)	 0	(0%)	 11	(0.5%)	 14	(0.7%)	 81	(3.8%)	
Acute	kidney	injury	N	
(%)	 24	(1.1%)	 22	(1.0%)	 0	(0%)	 10	 12	(0.6%)	 68	(3.2%)	
Anastomotic	leakage	N	
(%)	 12	(0.6%)	 12	(0.6%)	 5	(0.2%)	 20	(0.9%)	 6	(0.3%)	 55	(2.6%)	
Gastro-intestinal	
bleeding	N	(%)	 23	(1.1%)	 11	(0.5%)	 0	(0%)	 1	(0.1%)	 4	(0.2%)	 39	(1.8%)	
ARDS	N	(%)	 8	(0.4%)	 8	(0.4%)	 0	(0%)	 3	(0.1%)	 5	(0.2%)	 24	(1.1%)	
All	others	N	(%)	 84	(3.9%)	 80	(3.7%)	 7	(0.3%)	 11	(0.5%)	 9	(0.4%)	 191	(8.9%)	
	
Total	N	(%)	 434	(20.3%)	
380	
(17.8%)	
21	
(1.0%)	
139	
(6.5%)	
30	
(1.4%)	
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Table	3.	Results	of	the	multivariate	logistic	regression	model	for	postoperative	
complications	following	upper	gastrointestinal	surgery.	
ASA,	American	Society	of	Anesthesiologists	physical	status	score.	Data	presented	as	adjusted	odds	ratios	presented	
with	95%	confidence	intervals.	148	patients	were	omitted	from	the	multivariable	model	due	to	missing	data	on	one	
or	more	covariates.	Age:	no	reference.	Odds	ratio	for	age	is	indexed	to	years	of	difference	in	age,	so	that	in	the	
multivariable	model	odds	ratio	for	a	ten-year	increase	in	age	is	1.021	=	1.18.	ASA	was	treated	as	a	single	ordered	
categorical	variable	with	ASA	I	as	the	reference	to	all	other	categories	(OR=1.0).	Cirrhosis	–	reference:	no	cirrhosis.	
Intermediate	surgery	–	reference:	minor	surgery.	Major	surgery	–	reference:	minor	surgery.	Cancer	surgery	–	
reference:	non-cancer	surgery.	Open	Surgery	–	reference:	laparoscopic	surgery.	
	
	
	
 Multivariable	model	
OR	(95%CI)	 p-value	
Age	 1.02	(1.01-1.03)	 <0.001	
ASA	II	 1.13	(0.78-1.66)	 0.540	
ASA	III	 2.12	(1.44-3.16)	 <0.001	
ASA	IV	 3.23	(1.72-6.09	 <0.001	
Cirrhosis	 2.12	(0.91-4.78)	 0.072	
Intermediate	surgery	 1.75	(1.12-2.81)	 0.016	
Major	surgery	 2.65	(1.72-4.23)	 <0.001	
Cancer	Surgery	 1.63	(1.27-2.11)	 <0.001	
Open	surgery	 1.40	(1.10-1.78)	 0.006	
	Figure legend(s) 
 
 
 
 
 
Figure	legends	
	
	
	
Figure	1.	Patients,	hospital	and	countries	excluded	from	study.	
	
	
Figure	2.	Distribution	of	postoperative	complications	in	major	cancer	surgery	(n=578)	
and	other	upper	gastrointestinal	procedures	(n=1561).	
	Figure 1. 
 
 
 
 
 
Figure	1.	Patients,	hospital	and	countries	excluded	from	analysis.	
	
	
	
	
	
	
	
	
	
	
	
	
	
509	hospitals	participated	in	30	countries	(45,694	patients)	
	
Unsigned	datasheet	
(46	patients)	
Hospitals	with	fewer	
than	20	patients	
(27	hospitals,	323	
patients)	
Countries	with	fewer	
than	10	hospitals	
(3	countries,	8	
hospitals,	462	
patients)	
	
474	hospitals	(44,863	patients)	available	for	analysis	
Missing	outcome	data	
(52	patients)	
44,811	patients	in	all	surgical	procedure	categories	
2,139	patients	included	in	upper	gastrointestinal	surgery	analysis	
Excluded	surgery	
categories	
(42,672	patients)	
	Figure 2. 
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